International  Neutropenia researcher, Dr. Christopher Klein was awarded the top recognition at ASH this past December is a really BIG deal and highlights how far NEUTROPENIA has come since we started in 1989.


 His discoveries scientifically have contributed to helping the lives of so many with congenital neutropenia.  The William Dameshek Prize was awarded to Dr. Christoph Klein because of his pioneering research into the pathophysiology, the landmark discovery of mutations in HAX1 genes in patients with severe chronic neutropenia ( Kostmann disease) and the discovery of human P14/ROBLD3 deficiency and G6PC3 deficiency, genetic defects that can cause Kostmann syndromes. His contributions identified the genetic basis of several diseases on  the immune system and has had a large impact on the understanding of human blood and the immune system.